1 purchase reported after at least 12 months of silence — most recent on 20 Feb 2026.
Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Scibase Holding AB | -5,952,380 | net | 20 Feb 2026 | tx 2+5,952,380−11,904,760 |
| Infant Bacterial Therapeutics AB | 49,500 | net | 20 May 2023 | tx 4+49,500 |
| Xspray Pharma AB | 5,000 | net | 20 Nov 2024 | tx 5+15,000−10,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 20 Feb 2026 | PURCHASE | Scibase Holding AB | 5,952,380 | 0.20 SEK | first after silence |
| 05 Dec 2025 | SALE | Scibase Holding AB | 11,904,760 | 0.10 SEK | deriv |
| 20 Nov 2024 | SALE | Xspray Pharma AB | 10,000 | 0.01 USD | deriv |
| 05 Mar 2024 | PURCHASE |
| Xspray Pharma AB |
| 5,000 |
| 4.00 USD |
| 20 May 2023 | PURCHASE | Infant Bacterial Therapeutics AB | 20,000 | 3.29 SEK | deriv |
| 02 Mar 2023 | PURCHASE | Xspray Pharma AB | 3,000 | 6.41 USD |
| 28 Feb 2023 | PURCHASE | Xspray Pharma AB | 2,000 | 6.47 USD |
| 30 May 2022 | PURCHASE | Infant Bacterial Therapeutics AB | 20,000 | 7.00 SEK | deriv |
| 30 Nov 2021 | PURCHASE | Infant Bacterial Therapeutics AB | 5,500 | 7.70 USD |
| 04 May 2021 | PURCHASE | Infant Bacterial Therapeutics AB | 4,000 | 11.25 USD |